TNDM logo

TNDM Tandem Diabetes Care, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$17.70
+0.90 (+5.36%)

Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances t…

Market Cap: $1.24Bwww.tandemdiabetes.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
50
5 mentions
—
60d
50
7 mentions
—
90d
53
9 mentions
—
news: 9

Analyst Ratings

39 analysts
Buyconsensus
Strong Buy 0Buy 23Hold 16Sell 0Strong Sell 0
Avg price target$23.19+31.0%
Low $15.5Median $20.5High $40
Current Consensus

Revenue

$283.69M+881.22%
$18.98M$133.75M$248.52M$363.29M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-2.09
$-2.11–$-2.06
13 analysts
FY2026
$-0.60
$-0.70–$-0.50
16 analysts
FY2027
$0.04
$-0.39–$0.52
16 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
John F. Sheridan
Sector
Healthcare
Industry
Medical - Devices
Employees
2,500
Beta
1.59
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
0.53
www.tandemdiabetes.com